23.03.2013 Views

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

White Guide and Orange Guide Formatting Project - Pfizer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Orange</strong> <strong>Guide</strong> – Chapter 5: Interactions with Health Systems <strong>and</strong> Medical Groups<br />

with RMRS Colleagues”, as well as <strong>Pfizer</strong>’s policy around the h<strong>and</strong>ling of medical requests. Additionally,<br />

in a situation where both Medical <strong>and</strong> commercial colleagues are involved in a collaboration with a<br />

Health System, it is important that the <strong>Pfizer</strong> colleagues involved make it clear to the customer the two<br />

distinct roles <strong>and</strong> the respective functions. If possible, all documentation should reflect the distinct<br />

roles.<br />

Medical <strong>and</strong> Commercial Interactions<br />

Q. I am a Key Account Manager (KAM), <strong>and</strong> one of my large medical group<br />

customers has provided me with spreadsheets which contain data on a particular<br />

disease state related to that medical group, which includes an affiliated hospital.<br />

The group wants me to assist in analyzing the data in order assist them in better<br />

underst<strong>and</strong>ing the impact this disease has on hospital admissions. Some of this<br />

data is high-level such as total number of hospital admissions with a specific<br />

disease broken down by various common demographic categories: gender, age<br />

cohorts, etc. One spreadsheet inadvertently contains a de-identified list of<br />

specific patients, including length of admission, diagnosis, etc. Can the KAM<br />

receive this data from the customer <strong>and</strong> what analysis can they perform with it?<br />

A. In every situation where the customer wishes to provide patient data for analysis,<br />

the commercial field-based colleague should bring in their respective MOS<br />

colleague. While in some situations commercial field-based colleagues are able<br />

to perform high level analysis based on publicly available information, such<br />

situations are limited. Additionally, under no circumstance should any <strong>Pfizer</strong><br />

colleague receive de-identified patient specific information unless appropriate<br />

consents are in place <strong>and</strong> even then only <strong>Pfizer</strong> Medical Colleagues will be able to<br />

receive such information.<br />

Q. Can commercial field-based colleagues do joint customer presentations <strong>and</strong><br />

meetings with Medical Colleagues?<br />

A. Yes, commercial colleagues may do joint meetings <strong>and</strong> presentations with their<br />

Medical Colleagues for initial customer needs assessments as well as follow up<br />

meetings to discuss possible collaborations. Keep in mind that in order to protect<br />

the integrity of medical discussions, certain meetings may need to be separate<br />

meetings. Additionally, both <strong>Pfizer</strong> medical <strong>and</strong> commercial should be clear in<br />

their communications to the customer regarding the respective roles of medical<br />

<strong>and</strong> commercial in the particular project. The <strong>Orange</strong> <strong>Guide</strong> can guide you but<br />

you should speak to your Medical Colleague <strong>and</strong> team attorney who can help<br />

determine the best approach.<br />

112<br />

Rev. 09/12<br />

Page 17 of 18

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!